Fundraising Fox

Swift Biosciences

Ann Arbor, US · Founded 2009 · Delaware corporation · 1 known investors

Founders & leadership

TH
Tim HarkinsExecutive
DO
David OlsonExecutive
VM
Vladimir MakarovNamed on SEC filing

Board

PK
Peter KleinhenzBoard director
DW
Dan WatkinsBoard director
WY
Walter YoungBoard director
JB
Jack Ball, Jr.Board director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$24.5M disclosed across 6 rounds · 2012–2018

$4MraisedNov 2018 · 33 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Walter YoungDirector
  • Mark LewisDirector
  • Linda TuftsDirector
  • Dan KidleDirector
  • Nathan WoodExecutive Officer, Director
  • Jack BallDirector
  • Dan WatkinsDirector
Offering amount
$7M
Amount sold
$4M
First sale
Nov 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$12.2MraisedJun 2017 · 38 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Timothy Harkins, PhDExecutive Officer, Director
  • Peter KleinhenzDirector
  • Jack Ball, Jr.Director
  • Dan KidleDirector
  • Dan WatkinsDirector
  • Mark LewisDirector
  • Walter YoungDirector
  • Eric HalversonExecutive Officer
Offering amount
$12.2M
Amount sold
$12.2M
First sale
May 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$2.9MraisedJan 2017 · 28 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Dan WatkinsDirector
  • Walter YoungDirector
  • Peter KleinhenzDirector
  • Eric HalversonExecutive Officer
  • Jack Ball, Jr.Director
  • Vladimir MakarovExecutive Officer, Director
  • Timothy Harkins, PhDExecutive Officer, Director
Offering amount
$3.5M
Amount sold
$2.9M
First sale
Jan 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$3.3MraisedApr 2016 · 31 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter KleinhenzDirector
  • Dan WatkinsDirector
  • Eric HalversonExecutive Officer
  • Timothy Harkins, PhDExecutive Officer, Director
  • Walter YoungDirector
  • Jack Ball, Jr.Director
  • Vladimir MakarovExecutive Officer, Director
Offering amount
$5M
Amount sold
$3.3M
First sale
Apr 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.5MraisedSep 2015 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Walter YoungDirector
  • Peter KleinhenzDirector
  • Dan WatkinsDirector
  • Vladimir MakarovExecutive Officer, Director
  • Tim HarkinsExecutive Officer, Director
  • Jack Ball, Jr.Director
Offering amount
$2.5M
Amount sold
$1.5M
Minimum investment
$7K
First sale
Sep 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$500KraisedFeb 2012 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jack Ball, Jr.Director
  • Dan WatkinsDirector
  • Vladimir MakarovExecutive Officer, Director
  • Walter YoungDirector
  • David OlsonExecutive Officer, Director
Offering amount
$2M
Amount sold
$500K
Minimum investment
$17.5K
First sale
Feb 2012
Incorporated
Corporation, Delaware, 2009
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Swift Biosciences's investors?
Swift Biosciences's investors include Arboretum Ventures.
How much funding has Swift Biosciences raised?
Swift Biosciences has disclosed $24.5M raised across 6 rounds.
Where is Swift Biosciences headquartered?
Swift Biosciences is headquartered in Ann Arbor, US.